Cognitive Impairment and Fatigue After Mild to Moderate COVID-19
Conditions:   Post COVID-19 Condition;   Cognitive Impairment;   Fatigue, Mental Interventions:   Diagnostic Test: Neuropsychological investigation;   Diagnostic Test: Optometric investigation;   Diagnostic Test: Magnetic Resonance Imaging;   Diagnostic Test: Immunological biomarkers Sponsors:   Danderyd Hospital;   Karolinska Institutet;   Karolinska University Hospital;   Uppsala University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials

Contact Allergy to Rubber Accelerators - a Clinical Study
Condition:   Contact Allergy Interventions:   Other: Rubber accelerators and control chamber/solution for NON-SLS group;   Other: SLS;   Other: Rubber accelerators and control chamber/solution for SLS group;   Other: Patch test on back Sponsor:   National Allergy Research Center, Denmark Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials

Cognitive Impairment and Fatigue After Mild to Moderate COVID-19
Conditions:   Post COVID-19 Condition;   Cognitive Impairment;   Fatigue, Mental Interventions:   Diagnostic Test: Neuropsychological investigation;   Diagnostic Test: Optometric investigation;   Diagnostic Test: Magnetic Resonance Imaging;   Diagnostic Test: Immunological biomarkers Sponsors:   Danderyd Hospital;   Karolinska Institutet;   Karolinska University Hospital;   Uppsala University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials

Contact Allergy to Rubber Accelerators - a Clinical Study
Condition:   Contact Allergy Interventions:   Other: Rubber accelerators and control chamber/solution for NON-SLS group;   Other: SLS;   Other: Rubber accelerators and control chamber/solution for SLS group;   Other: Patch test on back Sponsor:   National Allergy Research Center, Denmark Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials

Cognitive Impairment and Fatigue After Mild to Moderate COVID-19
Conditions:   Post COVID-19 Condition;   Cognitive Impairment;   Fatigue, Mental Interventions:   Diagnostic Test: Neuropsychological investigation;   Diagnostic Test: Optometric investigation;   Diagnostic Test: Magnetic Resonance Imaging;   Diagnostic Test: Immunological biomarkers Sponsors:   Danderyd Hospital;   Karolinska Institutet;   Karolinska University Hospital;   Uppsala University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials

Study to Evaluate Safety, Tolerability and Explorative Efficacy of DM-101PX in Birch Pollen Allergic Participants
Condition:   Birch Pollen Allergy Interventions:   Biological: DM-101PX;   Biological: Placebo to Match DM-101PX Sponsor:   Desentum Oy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials

Biobanking for Biomarkers In Respiratory Disease, Allergic Diseases and/or Mast Cell Disorders
Conditions:   Allergic Diseases;   Asthma;   Mast Cell Disorders Intervention:   Sponsor:   University Hospital, Toulouse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials

Thresholds In Food Allergy evaluaTion And predictioN
Conditions:   Tree Nut Allergy;   Food Allergy Intervention:   Diagnostic Test: Oral food challenge Sponsors:   Hamilton Health Sciences Corporation;   AAAAI Foundation;   Canadian Institutes of Health Research (CIHR) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials

Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.
Conditions:   Allergic Rhinitis Due to Weed Pollen;   Allergic Rhinitis Interventions:   Drug: INI-2004;   Drug: Placebo Sponsors:   Inimmune Corporation;   Avance Clinical Pty Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials

Study to Evaluate Safety, Tolerability and Explorative Efficacy of DM-101PX in Birch Pollen Allergic Participants
Condition:   Birch Pollen Allergy Interventions:   Biological: DM-101PX;   Biological: Placebo to Match DM-101PX Sponsor:   Desentum Oy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials

Thresholds In Food Allergy evaluaTion And predictioN
Conditions:   Tree Nut Allergy;   Food Allergy Intervention:   Diagnostic Test: Oral food challenge Sponsors:   Hamilton Health Sciences Corporation;   AAAAI Foundation;   Canadian Institutes of Health Research (CIHR) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials

Biobanking for Biomarkers In Respiratory Disease, Allergic Diseases and/or Mast Cell Disorders
Conditions:   Allergic Diseases;   Asthma;   Mast Cell Disorders Intervention:   Sponsor:   University Hospital, Toulouse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials

Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.
Conditions:   Allergic Rhinitis Due to Weed Pollen;   Allergic Rhinitis Interventions:   Drug: INI-2004;   Drug: Placebo Sponsors:   Inimmune Corporation;   Avance Clinical Pty Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials

Study to Evaluate Safety, Tolerability and Explorative Efficacy of DM-101PX in Birch Pollen Allergic Participants
Condition:   Birch Pollen Allergy Interventions:   Biological: DM-101PX;   Biological: Placebo to Match DM-101PX Sponsor:   Desentum Oy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials

Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.
Conditions:   Allergic Rhinitis Due to Weed Pollen;   Allergic Rhinitis Interventions:   Drug: INI-2004;   Drug: Placebo Sponsors:   Inimmune Corporation;   Avance Clinical Pty Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials